These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3668853

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Role of isoflurane on hemodynamic properties and disposition of nicardipine.
    Chelly JE, Hysing ES, Abernethy DR, Doursout MF, Hartley CJ, Guerret M, Merin RG.
    J Pharmacol Exp Ther; 1987 Jun; 241(3):899-906. PubMed ID: 3598907
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characteristic cardiovascular effects of RA642, a pyrimido-pyrimidine derivative, in anesthetized dogs.
    Koyama S.
    J Pharmacol Exp Ther; 1985 May; 233(2):480-4. PubMed ID: 3999030
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cardiovascular interactions of local anesthetics and calcium entry blockers in conscious dogs.
    Edouard AR, Berdeaux A, Ahmad R, Samii K.
    Reg Anesth; 1991 May; 16(2):95-100. PubMed ID: 2043533
    [Abstract] [Full Text] [Related]

  • 8. Verapamil and nitrous oxide exert only minor effects on the normal myocardium in the presence of fentanyl.
    Ramsay JG, Arvieux CC, Diedericks J, Foëx P.
    Eur J Anaesthesiol; 1991 May; 8(3):203-12. PubMed ID: 1874218
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effects of lidocaine on systemic and coronary hemodynamics.
    Thomsen JH, Terry W, Stenlund RR, Querimit S, Rowe GG.
    Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):83-92. PubMed ID: 5123869
    [No Abstract] [Full Text] [Related]

  • 11. Dose-related cardiovascular effects of amrinone during enflurane anesthesia in the dog.
    Makela VH, Kapur PA.
    Anesth Analg; 1986 Aug; 65(8):849-52. PubMed ID: 3729021
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and dynamics of (+/-)-verapamil in lean and obese Zucker rats.
    Todd EL, Abernethy DR.
    J Pharmacol Exp Ther; 1986 Aug; 238(2):642-7. PubMed ID: 3735134
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hemodynamic profile of N-(2,5-dimethyl-1H-pyrrol-1-yl)6-(4-morpholinyl)-3-pyridazinamine hydrochloride in conscious dogs.
    Di Francesco GF, Baldoli E, Marchetti G, Glässer A.
    Arzneimittelforschung; 1986 Aug; 36(1):84-8. PubMed ID: 3954821
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative haemodynamic effects of lidocaine, mexiletine, and disopyramide.
    Beltrame J, Aylward PE, McRitchie RJ, Chalmers JP.
    J Cardiovasc Pharmacol; 1984 Aug; 6(3):483-90. PubMed ID: 6202976
    [Abstract] [Full Text] [Related]

  • 17. Cardiovascular effects of and interaction between calcium blocking drugs and anesthetics in chronically instrumented dogs: VII. Verapamil and thiopental.
    Hill DC, Wouters PF, Chelly JE, Doursout MF, Abernethy DR, Hartley CJ, Merin RG.
    Anesthesiology; 1989 Oct; 71(4):586-90. PubMed ID: 2802216
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hemodynamic effects of verapamil during fentanyl-nitrous oxide anesthesia.
    Griffin RM, Dimich I, Gurado R, Chiang H, Kaplan JA.
    Mt Sinai J Med; 1989 Mar; 56(2):93-6. PubMed ID: 2747674
    [Abstract] [Full Text] [Related]

  • 20. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ, Haitsma DB, van der Geest IE, Stubenitsky R, van Meegen JR, Man in't Veld AJ, Verdouw PD.
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.